Diagnosis and Therapy of Budd Chiari Syndrome

Overview

Journal Med Pharm Rep

Specialty General Medicine

Date 2021 Sep 16

PMID 34527916

Citations 2

Authors

Iulianna Lupasco

Vlada-Tatiana Dumbrava

Affiliations

Soon will be listed here.

Abstract

Budd-Chiari syndrome is described as a disorder characterized by the obstruction of hepatic venous outflow. The first description of the syndrome was done by George Budd in 1846. The etiology of the disease is multifactorial and requires differential diagnosing. The prognostic evaluation of patients with liver outflow obstruction differentiates special groups for further treatment procedures. The stepwise approach of Budd-Chiari syndrome allows the finding of the right technique on an individual basis for every patient.

Citing Articles

CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF PORTAL HYPERTENSION.

Grgurevic I, Filipec Kanizaj T, Ivekovic H, Mikolasevic I, Milic S, Mrzljak A Acta Clin Croat. 2025; 63(1):214-243.

PMID: 39959335 PMC: 11827405. DOI: 10.20471/acc.2024.63.01.26.

Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature.

Gaman M, Cozma M, Manan M, Srichawla B, Dhali A, Ali S World J Clin Oncol. 2023; 14(3):99-116.

PMID: 37009527 PMC: 10052333. DOI: 10.5306/wjco.v14.i3.99.

Renal cell carcinoma with right atrium tumor thrombus treated with radical nephrectomy and tumor thrombectomy in a patient with previous coronary artery bypass graft: a case report.

Ciancio G, Tabbara M, Farag A, Salerno T Am J Clin Exp Urol. 2022; 10(2):123-128.

PMID: 35528464 PMC: 9077144.

References

Bi Y, Chen H, Ding P, Ren J, Han X . Comparison of retrievable stents and permanent stents for Budd-Chiari syndrome due to obstructive inferior vena cava. J Gastroenterol Hepatol. 2018; 33(12):2015-2021. DOI: 10.1111/jgh.14295. View

Han G, Qi X, Zhang W, He C, Yin Z, Wang J . Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology. 2012; 266(2):657-67. DOI: 10.1148/radiol.12120856. View

Ki M, Choi H, Kim K, Kim B, Jang E, Jeong S . Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study. Liver Int. 2015; 36(7):1067-73. DOI: 10.1111/liv.13008. View

Ollivier-Hourmand I, Allaire M, Goutte N, Morello R, Chagneau-Derrode C, Goria O . The epidemiology of Budd-Chiari syndrome in France. Dig Liver Dis. 2018; 50(9):931-937. DOI: 10.1016/j.dld.2018.04.004. View

. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2015; 64(1):179-202. DOI: 10.1016/j.jhep.2015.07.040. View

Aydinli M, Bayraktar Y . Budd-Chiari syndrome: etiology, pathogenesis and diagnosis. World J Gastroenterol. 2007; 13(19):2693-6. PMC: 4147117. DOI: 10.3748/wjg.v13.i19.2693. View

Murad S, Kim W, de Groen P, Kamath P, Malinchoc M, Valla D . Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?. Liver Transpl. 2007; 13(6):867-74. DOI: 10.1002/lt.21171. View

Mancuso A . In favour of early intervention for Budd-Chiari syndrome: another brick in the wall. Eur J Gastroenterol Hepatol. 2016; 28(7):850-1. DOI: 10.1097/MEG.0000000000000653. View

Mukund A, Sarin S . Budd-Chiari syndrome: a focussed and collaborative approach. Hepatol Int. 2018; 12(6):483-486. DOI: 10.1007/s12072-018-9900-z. View

10.

Seijo S, Plessier A, Hoekstra J, DellEra A, Mandair D, Rifai K . Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 2013; 57(5):1962-8. DOI: 10.1002/hep.26306. View

11.

Langlet P, Escolano S, Valla D, Coste-Zeitoun D, Denie C, Mallet A . Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol. 2003; 39(4):496-501. DOI: 10.1016/s0168-8278(03)00323-4. View

12.

Murad S, Valla D, de Groen P, Zeitoun G, Hopmans J, Haagsma E . Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology. 2004; 39(2):500-8. DOI: 10.1002/hep.20064. View

13.

Goel R, Johnston E, Patel K, Wong T . Budd-Chiari syndrome: investigation, treatment and outcomes. Postgrad Med J. 2015; 91(1082):692-7. DOI: 10.1136/postgradmedj-2015-133402. View

14.

Rajani R, Melin T, Bjornsson E, Broome U, Sangfelt P, Danielsson A . Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience. Liver Int. 2008; 29(2):253-9. DOI: 10.1111/j.1478-3231.2008.01838.x. View

15.

Rautou P, Angermayr B, Garcia-Pagan J, Moucari R, Peck-Radosavljevic M, Raffa S . Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes. J Hepatol. 2009; 51(1):47-54. DOI: 10.1016/j.jhep.2009.02.028. View

16.

Garcia-Pagan J, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F . TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology. 2008; 135(3):808-15. DOI: 10.1053/j.gastro.2008.05.051. View

17.

Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A . Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology. 1999; 30(1):84-9. DOI: 10.1002/hep.510300125. View

18.

Zhang K, Xu H, Zu M, Wei N . [Predictive value of five prognostic models for Budd-Chiari syndrome in China]. Nan Fang Yi Ke Da Xue Xue Bao. 2014; 34(1):88-91. View

19.

Bachet J, Condat B, Hagege H, Plessier A, Consigny Y, Belghiti J . Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J Hepatol. 2006; 46(1):60-8. DOI: 10.1016/j.jhep.2006.08.016. View

20.

Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff S . Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol. 2003; 40(1):172-80. DOI: 10.1016/j.jhep.2003.09.028. View